Significant Ownership of Suvretta Capital Management, Llc

Signature - Title
/s/ Andrew Nathanson - Andrew Nathanson, General Counsel and Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Suvretta Capital Management, Llc.

Notify me when Suvretta Capital Management, Llc files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Suvretta Capital Management, Llc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BNTC Benitec Biopharma Inc. Common Stock, par value $0.0001 44.1% $249M $30M 17.8M +13.7% SUVRETTA CAPITAL MANAGEMENT, LLC Nov 7, 2025
MOLN MOLECULAR PARTNERS AG Common Shares, CHF 0.10 nominal value per share 10.6% $17.7M 4.28M SUVRETTA CAPITAL MANAGEMENT, LLC Jun 15, 2021
WHWK Aadi Bioscience, Inc. Common Stock, par value $0.0001 per share 9.99% $7.28M 4.73M SUVRETTA CAPITAL MANAGEMENT, LLC Mar 4, 2025
DBVT DBV Technologies S.A. Ordinary shares, nominal value 0.10 euro per share 9.9% $129M 15.2M SUVRETTA CAPITAL MANAGEMENT, LLC Apr 7, 2025
AVBP ArriVent BioPharma, Inc. Common Stock, $0.0001 Par Value per Share 9.9% $75.2M 3.41M Suvretta Capital Management, LLC Jun 30, 2025
IMTX Immatics N.V. ordinary shares, nominal value (euro)0.01 per share 9.9% $66.6M $16M 12M +31.7% Suvretta Capital Management, LLC Jun 30, 2025
KURA Kura Oncology, Inc. Common Stock, par value $0.0001 per share 9.4% $49.2M $15.4M 7.56M +45.5% SUVRETTA CAPITAL MANAGEMENT, LLC Mar 31, 2025
FULC Fulcrum Therapeutics, Inc. Common Stock, par value $0.001 per share 9.4% $18.5M $6.07M 5.07M +48.8% SUVRETTA CAPITAL MANAGEMENT, LLC Mar 31, 2025
CMPX Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share 8.2% $44.6M $22M 14.1M +97.2% Suvretta Capital Management, LLC Aug 13, 2025
STRO Sutro Biopharma, Inc. Common Stock, $0.001 par value 7.7% $4.63M 6.49M Suvretta Capital Management, LLC Jun 30, 2025
AURA Aura Biosciences, Inc. Common Stock, par value $0.00001 per share 7.6% $30.1M $10.5M 4.7M +53.8% Suvretta Capital Management, LLC Jun 30, 2025
PVLA Palvella Therapeutics, Inc. Common stock, $0.001 par value per share 7.4% $51.6M $6.77M 822K +15.1% SUVRETTA CAPITAL MANAGEMENT, LLC Sep 30, 2025
ETNB 89bio, Inc. Common Stock, par value $0.001 per share 5.6% $122M -$93.1M 8.28M -43.3% SUVRETTA CAPITAL MANAGEMENT, LLC Sep 30, 2025
GLUE Monte Rosa Therapeutics, Inc. Common stock, par value $0.0001 per share 5.5% $17.5M 3.36M SUVRETTA CAPITAL MANAGEMENT, LLC Apr 9, 2025
MRNS Marinus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 5.5% $1.66M $505K 3.02M +43.6% SUVRETTA CAPITAL MANAGEMENT, LLC Feb 7, 2025
ABEO Abeona Therapeutics Inc. Common Stock, $0.01 par value 5.2% $15.6M 2.68M Suvretta Capital Management, LLC Jun 30, 2025
ERAS Erasca, Inc. Common Stock, $0.0001 par value per share 5.1% $20.6M $3.11M 14.5M +17.8% Suvretta Capital Management, LLC Jun 30, 2025
PEPG PepGen Inc. Common Stock, par value $0.0001 per share 0.9% $354K -$1.61M 300K -81.9% SUVRETTA CAPITAL MANAGEMENT, LLC Jun 30, 2025

Schedules 13D/G Reported by Suvretta Capital Management, Llc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.